Engineering Proceedings (Jan 2025)
A Convolutional Neural Network for Early Supraventricular Arrhythmia Identification
Abstract
Supraventricular arrhythmias (SVAs), including the often-asymptomatic supraventricular extrasystole (SVE), pose significant challenges in early detection and precise diagnosis. These challenges are of paramount importance, as recurrent SVEs may elevate the risk of developing severe SVAs, potentially resulting in cardiac weakening and subsequent heart failure. In the study conducted, an innovative approach was introduced that combined a convolutional neural network (CNN) architecture to enable the early identification and characterization of SVEs within electrocardiogram (ECG) signals. The analysis leveraged a dataset comprising 78 half-hour recordings from the highly regarded MIT-BIH Arrhythmia Database, which included annotation headers serving as labels for each recording. Signals were down-sampled by a factor of 2 and split into windows of 512 samples, with 12,288 observations for training. Following the methodology, classic signal preprocessing techniques (filtering and data normalization) were used. The proposed model was based on the UNET 1D model. A binary cross-entropy loss function, Adam optimizer, and a batch size of 128 were obtained after a hyperparameter tuning. As a training-validation methodology, a 50-fold cross-validation technique was used. The approach demonstrated a Dice coefficient of 79.01%, a precision of 80.96%, and a recall rate of 86.60% in detecting SVE events. These findings were corroborated through meticulous comparison with the annotations provided by the MIT-BIH database. The results underscore the immense potential of CNN and deep learning techniques in the early detection of supraventricular arrhythmias. This approach not only offers a valuable tool for healthcare professionals engaged in telemonitoring and early intervention strategies but also represents a significant contribution to the field of cardiac health monitoring. By facilitating efficient and precise identification of SVEs, our research sets the stage for improved patient outcomes and the prevention of severe SVAs, marking substantial advancements in this critical domain.
Keywords